EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diacylglycerol kinase alpha is a proliferation marker of intrahepatic cholangiocarcinoma associated with the prognosis

Shunsuke Shichi iD, Ko Sugiyama, Yoh Asahi, Chisato Shirakawa, Hiroki Nakamoto, Saori Kimura, Kazuki Wakizaka iD, Takeshi Aiyama, Akihisa Nagatsu, Tatsuya Orimo, Tatsuhiko Kakisaka, Akinobu Taketomi

Cancer Medicine · 2024

DOI: 10.1002/cam4.7238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Shunsuke Shichi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Diacylglycerol Kinase, Biomarkers, Tumor, Bile Duct Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Ono Pharmaceutical Co., Ltd., Ministry of Education, Culture, Sports, Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intrahepatic cholangiocarcinoma (ICC) has a high recurrence rate and a poor prognosis. Thus, the development of effective treatment and prognostic biomarkers is required. High expression of diacylglycerol kinase alpha (DGKα) is a prognostic factor for the recurrence of hepatocellular carcinoma. However, the relationship between DGKα expression and prognosis in ICC has not been reported.

Methods

Immunohistochemistry (IHC) with anti‐DGKα antibody was performed on surgical specimens of ICC ( n = 69). First, DGKα expression in cancer cells was qualitatively classified into four groups (−, 1+, 2+, 3+) and divided into two groups (DGKα− and DGKα+1 + to 3+). The relationship between clinical features and DGKα expression was analyzed. Second, Ki‐67 expression was evaluated as a cell proliferation marker. The number of Ki‐67‐positive cells was counted, and the relationship with DGKα expression was examined.

Results

DGKα IHC divided the patients into a DGKα+ group (1+: n = 15; 2+: n = 5; 3+: n = 5) and a DGKα− group (−: n = 44). In the DGKα+ group, patients were older and had advanced disease. Both overall survival and recurrence‐free survival (RFS) were significantly worse in the DGKα+ patients. DGKα+ was identified as an independent prognostic factor for RFS by multivariate analysis. Furthermore, the number of Ki‐67‐positive cells increased in association with the staining levels of DGKα.

Conclusion

Pathological DGKα expression in ICC was a cancer proliferation marker associated with recurrence. This suggests that DGKα may be a potential therapeutic target for ICC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaDiacylglycerol KinaseBiomarkers, TumorBile Duct NeoplasmsCell ProliferationKi-67 AntigenHumansMaleFemalePrognosisMiddle AgedAgedAdultImmunohistochemistryNeoplasm Recurrence, Local

Stichwörter der Autor:innen

biomarkerdiacylglycerol kinaseintrahepatic cholangiocarcinomaprimary liver cancerprognostic factor

Substanzen

Diacylglycerol KinaseBiomarkers, TumorKi-67 Antigen

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

ORCID-Profile: Shunsuke Shichi, Kazuki Wakizaka

Förderung

  • Japan Agency for Medical Research and Development
  • Ono Pharmaceutical Co., Ltd.
  • Ministry of Education, Culture, Sports, Science and Technology
  • Ono Pharmaceutical

Zitieren

APA

Shichi, S., Sugiyama, K., Asahi, Y., Shirakawa, C., Nakamoto, H., Kimura, S., Wakizaka, K., Aiyama, T., Nagatsu, A., Orimo, T., Kakisaka, T., & Taketomi, A. (2024). Diacylglycerol kinase alpha is a proliferation marker of intrahepatic cholangiocarcinoma associated with the prognosis. Cancer Medicine. https://doi.org/10.1002/cam4.7238

Vancouver

Shichi S, Sugiyama K, Asahi Y, Shirakawa C, Nakamoto H, Kimura S, et al. Diacylglycerol kinase alpha is a proliferation marker of intrahepatic cholangiocarcinoma associated with the prognosis. Cancer Medicine. 2024. doi:10.1002/cam4.7238

BibTeX
@article{Shichi2024,
  author = {Shichi, Shunsuke and Sugiyama, Ko and Asahi, Yoh and Shirakawa, Chisato and Nakamoto, Hiroki and Kimura, Saori and Wakizaka, Kazuki and Aiyama, Takeshi and Nagatsu, Akihisa and Orimo, Tatsuya and Kakisaka, Tatsuhiko and Taketomi, Akinobu},
  title = {Diacylglycerol kinase alpha is a proliferation marker of intrahepatic cholangiocarcinoma associated with the prognosis},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.7238}
}
Kostenlos starten →